Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Hermel

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|September 10, 2025
Evaluation of ambulatory use of daratumumab hyaluronidase injectionNoah Vannarat, David J Hermel, Anne M Spengler
Journal of Dental Research|November 1, 1970
Fluoride uptake by enamel after immersion in 2 per cent sodium fluoride solution with iontophoresisI Gedalia, J Weinman, J Hermel, et al.
Future Oncology (London, England)|November 4, 2021
The role of Globo H and SSEA-4 in the development and progression of cancer, and their potential as therapeutic targetsDarren S Sigal, David J Hermel, Pei Hsu, et al.
Familial Cancer|April 30, 2017
Placing negative multi-gene panel results into clinical contextDavid J Hermel, Wendy C McKinnon, Marie E Wood, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|December 7, 2017
Cardiac birth defects in a twin infant born to a woman with chronic myeloid leukemia on dasatinibDavid J Hermel, Victor Chiu, Melody H Hermel, et al.
Familial Cancer|July 13, 2016
Multi-gene panel testing for hereditary cancer susceptibility in a rural Familial Cancer ProgramDavid J Hermel, Wendy C McKinnon, Marie E Wood, et al.
Annals of Hematology|February 26, 2022
Long-term outcomes of elderly hairy cell leukemia patients treated with cladribineDavid J Hermel, Brian Cheng, Munveer S Bhangoo, et al.
Journal of Clinical and Translational Hepatology|May 19, 2021
Checkpoint Inhibition in the Treatment of Unresectable, Advanced Lymphoepithelioma-like Hepatocellular CarcinomaDavid J Hermel, Emma Z Du, Ray Lin, et al.
Clinical Breast Cancer|May 26, 2017
Multi-institutional Evaluation of Women at High Risk of Developing Breast CancerDavid J Hermel, Marie E Wood, Jennifer Chun, et al.
Anti-Cancer Drugs|March 16, 2019
Gelatinous bone marrow transformation and emergence of clonal Philadelphia-negative cytogenetic abnormalities with excess blasts in a patient with chronic myeloid leukemia treated with dasatinibDavid J Hermel, Ali Nael, Yi-Tsung Lu, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|September 10, 2025
Evaluation of ambulatory use of daratumumab hyaluronidase injectionNoah Vannarat, David J Hermel, Anne M Spengler
Journal of Dental Research|November 1, 1970
Fluoride uptake by enamel after immersion in 2 per cent sodium fluoride solution with iontophoresisI Gedalia, J Weinman, J Hermel, et al.
Future Oncology (London, England)|November 4, 2021
The role of Globo H and SSEA-4 in the development and progression of cancer, and their potential as therapeutic targetsDarren S Sigal, David J Hermel, Pei Hsu, et al.
Familial Cancer|April 30, 2017
Placing negative multi-gene panel results into clinical contextDavid J Hermel, Wendy C McKinnon, Marie E Wood, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|December 7, 2017
Cardiac birth defects in a twin infant born to a woman with chronic myeloid leukemia on dasatinibDavid J Hermel, Victor Chiu, Melody H Hermel, et al.
Familial Cancer|July 13, 2016
Multi-gene panel testing for hereditary cancer susceptibility in a rural Familial Cancer ProgramDavid J Hermel, Wendy C McKinnon, Marie E Wood, et al.
Annals of Hematology|February 26, 2022
Long-term outcomes of elderly hairy cell leukemia patients treated with cladribineDavid J Hermel, Brian Cheng, Munveer S Bhangoo, et al.
Journal of Clinical and Translational Hepatology|May 19, 2021
Checkpoint Inhibition in the Treatment of Unresectable, Advanced Lymphoepithelioma-like Hepatocellular CarcinomaDavid J Hermel, Emma Z Du, Ray Lin, et al.
Clinical Breast Cancer|May 26, 2017
Multi-institutional Evaluation of Women at High Risk of Developing Breast CancerDavid J Hermel, Marie E Wood, Jennifer Chun, et al.
Anti-Cancer Drugs|March 16, 2019
Gelatinous bone marrow transformation and emergence of clonal Philadelphia-negative cytogenetic abnormalities with excess blasts in a patient with chronic myeloid leukemia treated with dasatinibDavid J Hermel, Ali Nael, Yi-Tsung Lu, et al.
Pageof 3